Discover Great Companies Discover Great Clients
Companies Salaries Jobs
Jobs |
Jobs Companies Salary Majors

Company Overview

Development Stage

About the Company

[Summary] 专注于抗肿瘤药品研发与国际营销的公司

东曜药业从事抗体及ADC药物开发10多年,具有丰富的工艺开发与商业化生产经验。公司于2019年在香港联交所主板上市,提供生物药研发到商业化生产一站式CDMO服务。
东曜药业拥有从研发、工艺开发、临床试验、注册报批到商业化生产的全流程经验,建立了完整的生物药与偶联技术平台,具备工艺开发,放大与验证的核心技术优势,以及药物关键质量属性的自主分析能力,保证产品高质量开发与生产。
在生产方面,东曜药业拥有多条集抗体/蛋白/ADC/Bioconjugates原液(包含非毒偶联)及制剂于一体的抗体与OEB-5级别ADC商业化生产线,抗体产能达万升级以上,并有商业化产品在线生产。
在质量体系方面,东曜药业质量管理体系满足中国/美国/欧盟/日本申报要求,通过国家药品注册生产现场和GMP质量管理体系核查,具有丰富的产品上市注册核查经验。已为客户提供百余个项目的工艺开发、临床申报及生产服务。
东曜药业秉持“以品质 助创新 共成长”的服务理念,为产品高质量研发与商业化生产保驾护航,赋能合作伙伴,共创双赢。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

东曜药业 Financing History (2 rounds)

Manage
IPO
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market:
  • Deal:

东曜药业 How Fast Is Hiring Growing? (25 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 131%
  • 2024: Down 42%
  • 2023: Up 138%
  • 2022: Down 53%
东曜药业 Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
东曜药业 Campus Recruitment & Advanced Degree Talent Demand
Graduates 1 Interns 1
Note: How fast is hiring at 东曜药业有限公司 growing? 东曜药业2025年127个(增长131%),2024年55个(下降42%),2023年95个(增长138%),2022年40个(下降53%),2021年85个. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

东曜药业 Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 138%
  • 2024: Down 50%
  • 2023: Up 100%
  • 2022: Up 14%
东曜药业 Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 东曜药业有限公司 growing? 东曜药业历年硕士招聘职位量:2025年19个(增长138%),2024年8个(下降50%),2023年16个(增长100%),2022年8个(增长14%),2021年7个.

东曜药业 Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
东曜药业 Doctoral Hiring by Year: 2024 — same as 2023
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 东曜药业有限公司 growing? 东曜药业历年博士招聘职位量:2024年1个(下降50%),2023年1个(增长100%).

东曜药业 R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 东曜药业有限公司? Based on an analysis of 东曜药业's job postings over the past year, “生物/制药/化工/环保类”需求占44.1%,“其他(研发和技术类)”占21.6%,“科研类”占20.6%,“机械/仪器仪表类”占2.9%,“医疗卫生/美容保健类”占2%,“电气/能源/动力类”占1%. For reference only.

东曜药业 — What Are the Salaries Like? (102 records)

Manage
salary range: 2K - 50K, 62.7% of roles pay ¥8-15K
Note: salary statistics are based on 102 salary records from the past year and depend on the job sample. For reference only.
东曜药业有限公司工资待遇怎么样?东曜药业62.7%的岗位拿8-15K,应届生工资¥9.7K。与同行业比-12%,生物/制药/化工/环保类平均工资¥11.0K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of 东曜药业

(More)
Are salaries high at 东曜药业有限公司? We provide: 研究员,分析,运营,qc,管培生,拓展,物料计划,理化工程师,实习生,灌装,冻干工程师,设备工,财务,车间,配液工程师,qa,数据专员,注册专员,注册主管,生产工. Click to view detailed salary analysis by job.

东曜药业 — Fortune 500? (More)

Yes, ranked in 中国生命科学服务100强:

东曜药业 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

东曜药业 Related Industry Tags

Job Category

  • 生物/制药/化工/环保类
    45.3% of total 45.3%
  • 在校学生类
    42.5% of total 42.5%
  • 工厂生产类
    21.7% of total 21.7%
  • 其他(研发和技术类)
    20.8% of total 20.8%

Education

  • 本科
    53.8% of total 53.8%
  • 大专
    21.7% of total 21.7%
  • 硕士
    20.8% of total 20.8%
  • 不限
    3.8% of total 3.8%

Experience

  • 应届生
    40.6% of total 40.6%
  • 不限
    21.7% of total 21.7%
  • 1-3年
    17.9% of total 17.9%
  • 5-10年
    10.4% of total 10.4%
View Detailed Analysis

What does 东曜药业有限公司 require? Who is 东曜药业 hiring? 东曜药业招聘类别生物/制药/化工/环保类占比最多占45.3%,其次是在校学生类占42.5%。东曜药业什么学历能进?本科占比最多占53.8%,其次是大专占21.7%。东曜药业学历要求高吗?硕士占20.8%。工作经验东曜药业有什么要求?应届生占比最多占40.6%,其次是不限占21.7%。东曜药业工作地区在哪?苏州占比最多占100%。 Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 27,760万(美元)
Legal Representative: 付山
Date Established:
Credit Code: 913205945580152601
Registered Address: 苏州工业园区长阳街120号

Partners & Suppliers

与启德医药共同开发抗体偶联药物(ADC) Source
供应商 生物药合作开发
授权东曜药业KN026(抗HER2双特异性抗体)在大中华区的独家开发及商业化权利 Source
供应商 技术授权/许可
提供色谱填料和分离纯化解决方案,支持东曜药业抗体药物研发及生产 Source
供应商 分离纯化填料

People who follow 东曜药业 also follow

东曜药业 Competitors (Similar Companies)

“开发老百姓都用得着、用得起的高质量的生物药”
“持续创新,护佑健康”
“为全球肿瘤患者带来更好的治疗方案”
制药/药业 生物制药 制药 医药中间体
医药 生物医药 制药 创新药
“抗肿瘤药和手术用药的研究和生产”
制药/药业 医药 制药 医药中间体
“致力于创新药物的自主研发、生产和销售”
“提供个体化治疗和健康管理的解决方案”
“成为一个具有存在价值、为人类健康保健服务的企业”
“提供基因/细胞治疗工艺开发和生产一体化服务”
“开发基于RNA干扰(RNAi)技术的核酸药物”
“生物制药工艺开发与大规模生产”
“中国中枢神经药物领域领先企业”
“为全球一百多家制药厂及生物技术公司提供咨询和服务”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates

宠物医院
客服
由百度提供